NALUZOTAN
UNII LQ54E5B4EW

Substance Identification & Data

This profile provides standardized clinical and technical data for Naluzotan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LQ54E5B4EW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 740873-06-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LQ54E5B4EW

CAS Registry Number

740873-06-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NALUZOTAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H38N4O3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

SPWZXWDPAWDKQE-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C80775

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11430856

Unique identification number in the NCBI database of chemical substances.

INN ID

9062

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

UU-17

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(CCCNS(=O)(=O)CC1CCCCC1)N2CCN(CC2)c3cc(NC(=O)C)ccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Naluzotan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.